118 related articles for article (PubMed ID: 38403662)
1. Self-controlled Case Series Study for Acute Kidney Injury after Starting Proton Pump Inhibitors or Potassium-Competitive Acid Blocker in Patients with Cancer Using a Large Claims Database.
Suzuki K; Watanabe A; Kiryu Y; Inoue E; Momo K
Biol Pharm Bull; 2024; 47(2):518-526. PubMed ID: 38403662
[TBL] [Abstract][Full Text] [Related]
2. Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study.
Hart E; Dunn TE; Feuerstein S; Jacobs DM
Pharmacotherapy; 2019 Apr; 39(4):443-453. PubMed ID: 30779194
[TBL] [Abstract][Full Text] [Related]
3. Use of proton pump inhibitors and macrolide antibiotics and risk of acute kidney injury: a self-controlled case series study.
Ikuta K; Nakagawa S; Yamawaki C; Itohara K; Hira D; Imai S; Yonezawa A; Nakagawa T; Sakuragi M; Sato N; Uchino E; Yanagita M; Terada T
BMC Nephrol; 2022 Nov; 23(1):383. PubMed ID: 36451129
[TBL] [Abstract][Full Text] [Related]
4. Association of proton pump inhibitors and concomitant drugs with risk of acute kidney injury: a nested case-control study.
Ikuta K; Nakagawa S; Momo K; Yonezawa A; Itohara K; Sato Y; Imai S; Nakagawa T; Matsubara K
BMJ Open; 2021 Feb; 11(2):e041543. PubMed ID: 33589451
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury.
Leonard CE; Freeman CP; Newcomb CW; Reese PP; Herlim M; Bilker WB; Hennessy S; Strom BL
Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1155-72. PubMed ID: 22887960
[TBL] [Abstract][Full Text] [Related]
6. Acute kidney injury following the use of different proton pump inhibitor regimens: A real-world analysis of post-marketing surveillance data.
Chen G; Ning LJ; Qin Y; Zhao B; Mei D; Li XM
J Gastroenterol Hepatol; 2021 Jan; 36(1):156-162. PubMed ID: 32542684
[TBL] [Abstract][Full Text] [Related]
7. Identification of the Components of Proton Pump Inhibitors and Potassium-Competitive Acid Blocker That Lead to Cardiovascular Events in Working-Age Individuals: A 12-Month Retrospective Cohort Study Using a Large Claims Database.
Watanabe A; Momo K; Tanaka K; Uchikura T; Kiryu Y; Niiyama K; Kodaira N; Matsuzaki A; Sasaki T
Biol Pharm Bull; 2022; 45(9):1373-1377. PubMed ID: 36047207
[TBL] [Abstract][Full Text] [Related]
8. Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury.
Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
Kidney Int; 2017 Jun; 91(6):1482-1494. PubMed ID: 28237709
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors and the risk of acute kidney injury in cancer patients receiving immune checkpoint inhibitors: A Danish population-based cohort study.
Munch PV; Nørgaard M; Heide-Jørgensen U; Jensen SK; Birn H; Christiansen CF
Int J Cancer; 2024 Apr; 154(7):1164-1173. PubMed ID: 37983738
[TBL] [Abstract][Full Text] [Related]
10. The association between proton pump inhibitor use and risk of post-hospitalization acute kidney injury: a multicenter prospective matched cohort study.
Zhang Y; Ghahramani N; Razjouyan H; Ba DM; Chinchilli VM
BMC Nephrol; 2023 May; 24(1):150. PubMed ID: 37237361
[TBL] [Abstract][Full Text] [Related]
11. Impact of combining vancomycin with proton pump inhibitors on the incidence of acute kidney injury.
Aljohani HA; Alharbi HA; Basurrah SA; Alamoudi SA; Thabit AK
Basic Clin Pharmacol Toxicol; 2022 Sep; 131(3):189-195. PubMed ID: 35665603
[TBL] [Abstract][Full Text] [Related]
12. Proton Pump Inhibitors Are Not Associated With Acute Kidney Injury in Critical Illness.
Lee J; Mark RG; Celi LA; Danziger J
J Clin Pharmacol; 2016 Dec; 56(12):1500-1506. PubMed ID: 27492273
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitors associated acute kidney injury and chronic kidney disease: data mining of US FDA adverse event reporting system.
Wu B; Li D; Xu T; Luo M; He Z; Li Y
Sci Rep; 2021 Feb; 11(1):3690. PubMed ID: 33574396
[TBL] [Abstract][Full Text] [Related]
14. Proton Pump Inhibitors Augment the Risk of Major Adverse Cardiovascular Events and End-Stage Renal Disease in Patients With Acute Kidney Injury After Temporary Dialysis.
Tsai IJ; Lai TS; Shiao CC; Huang TM; Wang CH; Tsao CH; Chen LW; Lin YH; Chen L; Wu VC; Chu TS;
Clin Pharmacol Ther; 2020 Jun; 107(6):1434-1445. PubMed ID: 31901200
[TBL] [Abstract][Full Text] [Related]
15. The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors.
Seethapathy H; Zhao S; Chute DF; Zubiri L; Oppong Y; Strohbehn I; Cortazar FB; Leaf DE; Mooradian MJ; Villani AC; Sullivan RJ; Reynolds K; Sise ME
Clin J Am Soc Nephrol; 2019 Dec; 14(12):1692-1700. PubMed ID: 31672794
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors of acute kidney injury in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
Liu C; Wei W; Yang L; Li J; Yi C; Pu Y; Yin T; Na F; Zhang L; Fu P; Zhao Y
Front Immunol; 2023; 14():1173952. PubMed ID: 37313406
[TBL] [Abstract][Full Text] [Related]
17. Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies.
Yang Y; George KC; Shang WF; Zeng R; Ge SW; Xu G
Drug Des Devel Ther; 2017; 11():1291-1299. PubMed ID: 28479851
[TBL] [Abstract][Full Text] [Related]
18. Risk of acute kidney injury in patients with HIV receiving proton pump inhibitors.
Sutton SS; Magagnoli J; Cummings TH; Hardin JW
J Comp Eff Res; 2019 Jul; 8(10):781-790. PubMed ID: 31167563
[No Abstract] [Full Text] [Related]
19. A Potassium-Competitive Acid Blocker-Based Regimen as Second-Line Therapy Improves Helicobacter pylori Eradication.
Nabeta H; Shinozaki S; Abe Y; Koyanagi R; Nakamichi T; Kobayashi Y; Lefor AK; Hirashima H
Digestion; 2020; 101(3):332-338. PubMed ID: 30991394
[TBL] [Abstract][Full Text] [Related]
20. Acute Kidney Injury in Patients Receiving Systemic Treatment for Cancer: A Population-Based Cohort Study.
Kitchlu A; McArthur E; Amir E; Booth CM; Sutradhar R; Majeed H; Nash DM; Silver SA; Garg AX; Chan CT; Kim SJ; Wald R
J Natl Cancer Inst; 2019 Jul; 111(7):727-736. PubMed ID: 30423160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
